pancreatic beta cell modulators (DiogenX)

N/A

Report date: 2025/03/19 11:44:56

Base Information

Drug Namepancreatic beta cell modulators (DiogenX)
Drug Alias Namerecombinant protein (DiogenX)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionRegenerating islet-derived protein 3-alpha modulators
TargetsRegenerating islet-derived protein 3-alpha
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDiogenX
China Registration ClassN/A

Develop Information

Active CompaniesDiogenX
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A